These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31155576)

  • 1. A Photo-Activatable Peptide Mimicking Functions of Apolipoprotein A-I.
    Kawahara H; Miyashita N; Tachibana K; Tsuda Y; Morimoto K; Tsuji K; Shigenaga A; Otaka A; Ishida T; Okuhira K
    Biol Pharm Bull; 2019; 42(6):1019-1024. PubMed ID: 31155576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.
    Xie Q; Zhao SP; Li F
    Tohoku J Exp Med; 2010 Mar; 220(3):223-8. PubMed ID: 20208418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.
    D'Souza W; Stonik JA; Murphy A; Demosky SJ; Sethi AA; Moore XL; Chin-Dusting J; Remaley AT; Sviridov D
    Circ Res; 2010 Jul; 107(2):217-27. PubMed ID: 20508181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.
    White CR; Datta G; Wilson L; Palgunachari MN; Anantharamaiah GM
    Chem Phys Lipids; 2019 Mar; 219():28-35. PubMed ID: 30707910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux.
    Islam RM; Pourmousa M; Sviridov D; Gordon SM; Neufeld EB; Freeman LA; Perrin BS; Pastor RW; Remaley AT
    Sci Rep; 2018 Feb; 8(1):2956. PubMed ID: 29440748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE
    Gou S; Wang L; Zhong C; Chen X; Ouyang X; Li B; Bao G; Liu H; Zhang Y; Ni J
    Br J Pharmacol; 2020 Oct; 177(20):4627-4644. PubMed ID: 32726461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter.
    Sviridov DO; Drake SK; Freeman LA; Remaley AT
    Biochem Biophys Res Commun; 2016 Mar; 471(4):560-5. PubMed ID: 26879139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
    Anantharamaiah GM; Garber DW; White CR
    Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of α-methylated amino acids into Apolipoprotein A-I mimetic peptides improves their helicity and cholesterol efflux potential.
    Islam R; Sviridov DO; Drake SK; Tunyi J; Abdoulaeva G; Freeman LA; Pastor RW; Remaley AT
    Biochem Biophys Res Commun; 2020 May; 526(2):349-354. PubMed ID: 32222278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.
    Ditiatkovski M; D'Souza W; Kesani R; Chin-Dusting J; de Haan JB; Remaley A; Sviridov D
    PLoS One; 2013; 8(7):e68802. PubMed ID: 23874769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesis.
    Hafiane A; Genest J
    Atherosclerosis; 2017 Feb; 257():90-99. PubMed ID: 28129550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention of α-helical structure by HDL mimetic peptide ATI-5261 upon extensive dilution represents an important determinant for stimulating ABCA1 cholesterol efflux with high efficiency.
    Zheng Y; Patel AB; Narayanaswami V; Bielicki JK
    Biochem Biophys Res Commun; 2013 Nov; 441(1):71-6. PubMed ID: 24129191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
    Hafiane A; Bielicki JK; Johansson JO; Genest J
    PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
    Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt inhibition promotes ABCA1-mediated cholesterol efflux to ApoA-I through suppressing mTORC1.
    Dong F; Mo Z; Eid W; Courtney KC; Zha X
    PLoS One; 2014; 9(11):e113789. PubMed ID: 25415591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.